RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Flexion Therapeutics - Stock

Flexion Therapeutics Revenue 2024

Flexion Therapeutics Revenue

294.55 M USD

Flexion Therapeutics Dividend yield

Ticker

FLXN

ISIN

US33938J1060

WKN

A1XEDR

In 2024, Flexion Therapeutics's sales reached 294.55 M USD, a 37.08% difference from the 214.87 M USD sales recorded in the previous year.

The Flexion Therapeutics Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2025e411.8416,10
2024e294.5522,51
2023e214.8730,86
2022e161.3141,10
2021e110.1660,19
202085.5577,50
201972.9686,35
201822.5267,45
20170.3697,22
2016--
2015--
2014--
2013--
2012--
2011--

Flexion Therapeutics Aktienanalyse

What does Flexion Therapeutics do?

Flexion Therapeutics is a biotechnology company specializing in the development and marketing of drugs for the treatment of pain and inflammation. The company was founded in 2007 and is headquartered in Burlington, Massachusetts. Flexion Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Flexion Therapeutics's Sales Figures

The sales figures of Flexion Therapeutics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Flexion Therapeutics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Flexion Therapeutics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Flexion Therapeutics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Flexion Therapeutics Stock

How much revenue did Flexion Therapeutics generate this year?

Flexion Therapeutics has achieved a revenue of 294.55 M USD this year.

How much was the turnover of the company Flexion Therapeutics compared to the previous year?

The revenue of Flexion Therapeutics has increased by 37.08% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Flexion Therapeutics?

The revenue of Flexion Therapeutics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Flexion Therapeutics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Flexion Therapeutics so important for investors?

The revenue of Flexion Therapeutics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Flexion Therapeutics pay?

Over the past 12 months, Flexion Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Flexion Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Flexion Therapeutics?

The current dividend yield of Flexion Therapeutics is .

When does Flexion Therapeutics pay dividends?

Flexion Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Flexion Therapeutics?

Flexion Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Flexion Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Flexion Therapeutics located?

Flexion Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Flexion Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Flexion Therapeutics from 6/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.

When did Flexion Therapeutics pay the last dividend?

The last dividend was paid out on 6/6/2024.

What was the dividend of Flexion Therapeutics in the year 2023?

In the year 2023, Flexion Therapeutics distributed 0 USD as dividends.

In which currency does Flexion Therapeutics pay out the dividend?

The dividends of Flexion Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Flexion Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Flexion Therapeutics

Our stock analysis for Flexion Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Flexion Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.